Last reviewed · How we verify
Motore
At a glance
| Generic name | Motore |
|---|---|
| Also known as | Group 1 |
| Sponsor | Ache Laboratorios Farmaceuticos S.A. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cognitive Recovery Via Sensor-based Robotic Upper Limb Rehabilitation in Neurological Disorders (NA)
- Clinical validatiOn of an AI-based DEcision Support System for Robotic Upper Limb Rehabilitation in Patients With Stroke. A CO-AIDER Study. (NA)
- Multicenter Study That Offers New Solutions for Paediatric Rehabilitation by Proposing a Rehabilitation Plan Based on Each Child's Needs Using New Technological and Robotic Devices, Combined Among Them. (NA)
- Upper Limb Rehabilitation in People With Parkinson's Disease: (NA)
- Robotic rEhabilitation sCenario fOr patieNts With NeglECT (NA)
- Evaluation of a Haptic Glove for Assessing Tactile Perception in Post-Stroke Patients (NA)
- Sensory and Cognitive Outcomes of Robotic Exercises in Stroke (SCORES) (NA)
- Nutritional Status in Subacute Stroke Patients Under Rehabilitation 2.0
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Motore CI brief — competitive landscape report
- Motore updates RSS · CI watch RSS
- Ache Laboratorios Farmaceuticos S.A. portfolio CI